DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
scyllo-inositol is an investigational drug.
There have been 4 clinical trials for scyllo-inositol. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2012.
The most common disease conditions in clinical trials are Alzheimer Disease, Psychomotor Agitation, and Aggression. The leading clinical trial sponsors are Transition Therapeutics Ireland Limited, Elan Pharmaceuticals, and Transition Therapeutics.
Recent Clinical Trials for scyllo-inositol
|Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease||Elan Pharmaceuticals||Phase 2|
|Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease||Transition Therapeutics Ireland Limited||Phase 2|
|Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder||Elan Pharmaceuticals||Phase 2|